Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s footer is updated to reflect a new software/website revision (from v3.5.2 to v3.5.3). This represents a versioning change rather than a change to the trial information.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0. This update appears to be an internal version change with no observable changes to study information.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 removed, indicating a minor update. No visible changes to core content or user-facing functionality.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page shows a revision from v3.4.1 to v3.4.2, representing a small metadata update with no substantive changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check97 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1; no observable changes to study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.